Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice.

MLA

Seidel, Florine, et al. “Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice.” International Journal of Molecular Sciences, vol. 23, no. 18, Sept. 2022. EBSCOhost, https://doi.org/10.3390/ijms231810736.

APA

Seidel, F., Kleemann, R., van Duyvenvoorde, W., van Trigt, N., Keijzer, N., van der Kooij, S., van Kooten, C., Verschuren, L., Menke, A., Kiliaan, A. J., Winter, J., Hughes, T. R., Morgan, B. P., Baas, F., Fluiter, K., & Morrison, M. C. (2022). Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice. International Journal of Molecular Sciences, 23(18). https://doi.org/10.3390/ijms231810736

Chicago

Seidel, Florine, Robert Kleemann, Wim van Duyvenvoorde, Nikki van Trigt, Nanda Keijzer, Sandra van der Kooij, Cees van Kooten, et al. 2022. “Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice.” International Journal of Molecular Sciences 23 (18). doi:10.3390/ijms231810736.